State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 Xianlie Road, Guangzhou, 510060, China.
Graefes Arch Clin Exp Ophthalmol. 2021 Oct;259(10):2929-2939. doi: 10.1007/s00417-021-05196-y. Epub 2021 Apr 27.
The pathogenic variants in TSPAN12 could lead to familial exudative vitreoretinopathy (FEVR), which has high clinical variability. This study aims to assess the pathogenicity of TSPAN12 variants and their phenotypic spectrum based on exome sequencing from 7092 probands with different eye conditions.
The variants in TSPAN12 were selected from exome sequencing data of samples from 7092 probands with different forms of eye conditions. Potentially pathogenic variants were evaluated through the annotation of types, locations, population frequencies, and in silico predictions of variants from in-house data, gnomAD, and published literature. The clinical features of patients with potentially pathogenic variants in TSPAN12 were assessed.
A total of 45 variants in TSPAN12 with coding effects were detected based on the exome data from 7092 probands, among which 31 were classified as pathogenic variants including 15 novels. The 31 variants were identified in 34 probands with various initial diagnoses, including FEVR in 21 probands and diseases other than FEVR in the remaining 13 probands. Biallelic pathogenic variants were identified in one proband with initial diagnosis of high myopia.
Truncating variants and the missense variants that are predicted as deleterious are likely pathogenic variants of TSPAN12. Approximately 61.8% of patients with pathogenic variants in this gene had an initial diagnosis of FEVR, and the remaining 38.2% of patients had various initial diagnoses. These findings expand the understanding about variant evaluation of TSPAN12 and phenotypic spectrum of TSPAN12-associated FEVR.
TSPAN12 的致病变体可导致家族性渗出性玻璃体视网膜病变(FEVR),其临床表现高度异质。本研究旨在通过对 7092 名不同眼部疾病患者的外显子组测序,评估 TSPAN12 变体的致病性及其表型谱。
从 7092 名不同眼部疾病患者的外显子组测序数据中选择 TSPAN12 中的变体。通过对变体类型、位置、群体频率以及来自内部数据、gnomAD 和已发表文献的变体的计算预测进行注释,评估潜在致病变体。评估 TSPAN12 中具有潜在致病变体的患者的临床特征。
根据 7092 名患者的外显子组数据,共检测到 45 个具有编码效应的 TSPAN12 变异,其中 31 个被归类为致病性变异,包括 15 个新变异。这 31 个变体在 34 名具有不同初始诊断的患者中被识别,包括 21 名患者的 FEVR 和其余 13 名患者的非 FEVR 疾病。一名初始诊断为高度近视的患者中发现了双等位基因致病性变异。
截断变异和预测为有害的错义变异可能是 TSPAN12 的致病变异。该基因中致病性变异患者的约 61.8%有 FEVR 的初始诊断,其余 38.2%的患者有各种初始诊断。这些发现扩展了对 TSPAN12 变异评估和 TSPAN12 相关 FEVR 表型谱的理解。